Executive Committee

The Executive Committee is composed of Drs. Felson, Neogi, LaValley, and Fournier. These are the Director, Associate Director, Methodology Core Director and Director of Evaluation, respectively as well as Sharon Tomlinson, Administrative Manager. The Executive Committee meets quarterly.

External Advisory Committee

The External Advisory Committee is responsible for advising the Executive Committee on the overall direction of the center and for integrating its activities into a cohesive program consistent with center goals. It also examines reviews of P+F grant submissions and decides on which are to be funded, and serves as a backup resource to resolve Center conflicts.

Members of the External Advisory Committee are as follows

  • Chair: Dr. Sandro Galea, Dean, BU School of Public Health
  • David Salant, Professor of Medicine, Vice Chair of Medicine for Research
  • Alan Jette, Professor of Rehabilitation Sciences, Former Dean of Sargent College of Allied Health Professionals
  • Belinda Borrelli, Professor of Health Services, Psychologist focusing on adherence interventions; Director of BU Affinity Research Collaboration on mobile health (“mHealth”)
  • Katherine Liao, Associate Professor of Medicine (Rheumatology and Bioinformatics), Harvard Medical School

Core Faculty

Maureen Dubreuil, MD, MSc
David Felson, MD, MPH
Reza Jafarzadeh, DVM, MPVM, PhD
Vijaya Kolachalama, PhD, FAHA
Deepak Kumar, PT, PhD
Michael LaValley, PhD
Cara Lewis, PhD
Tuhina Neogi, MD, PhD
Michelle Yau, MD

Patient Advisory Group

The Boston MCRC Patient Advisory Group, comprised of selected patients from Boston Medical Center with targeted diseases, assembles annually to provide feedback on planned projects. We solicit their input on priorities for research, and on study design, outcomes, and recruitment strategies as well as advice regarding respectful and meaningful ways of engaging and partnering with patients and communities, and optimal means of communicating study results to non-medical audiences. Select MCRC members present study highlights to the Patient Advisory Group for specific feedback. Since annual meetings are not sufficient for the extent of feedback desired, selected patients from this group are asked to provide more frequent individual feedback on studies.

Through our ongoing collaborations with the Boston University Clinical Translational Science Institute, the Boston University School of Public Health and the BU Medical Campus Community Engagement Program we will continue to identify research advocates who have been trained in the principles of clinical research and preferentially recruit these persons to our Patient Advisory Group.

Representative of the MCRC Research Community

Given the importance of the MCRC’s service to the research community, we have appointed Dr. Douglas Kiel to aid in addressing their needs. Dr. Kiel is Director of the Framingham Osteoporosis Study, Professor of Medicine at Harvard and recent President of the American Society for Bone and Mineral Research. Each year the research community will be surveyed to determine whether they have experienced benefit from the MCRC, what strengths they see from their liaison and what needs they have that might be addressed by the Center. This survey will be designed by Dr. Fournier, Assistant Provost for Evaluation and member of the Executive Committee, Dr. Felson, and Dr. Kiel.